Comparison Of Liver Cell Models Using The Basel Phenotyping Cocktail

Comparison Of Liver Cell Models Using The Basel Phenotyping Cocktail

Currently used hepatocyte cell systems for in vitro assessment of drug metabolism include hepatoma cell lines and primary human hepatocyte (PHH) cultures. We investigated the suit-ability of the validated in vivo Basel phenotyping cocktail (caffeine [CYP1A2], efavirenz [CYP2B6], losartan [CYP2C9],...

Full description

Bibliographic Details
Main Authors:	Benjamin Berger, Massimiliano Donzelli, Swarna Maseneni, Franziska Boess, Adrian Roth, Stephan Krähenbühl, Manuel Haschke
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-11-01
Series:	Frontiers in Pharmacology
Subjects:	CYP induction Liquid chromatography tandem mass spectrometry Cytochrome P450 (CYP) Basel cocktail 3-dimensional spheroid primary human hepatocyte culture
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00443/full

Similar Items

The Development and Validation of a Novel “Dual Cocktail” Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions
by: Mihwa Kwon, et al.
Published: (2020-09-01)

Impact of Obesity and Bariatric Surgery on Metabolic Enzymes and P-Glycoprotein Activity Using the Geneva Cocktail Approach
by: Hengameh Ghasim, et al.
Published: (2023-06-01)

Critical Assessment of Phenotyping Cocktails for Clinical Use in an African Context
by: Machel Leuschner, et al.
Published: (2023-07-01)

Changes in cytochrome P450 gene expression and enzyme activity induced by xenobiotics in rabbits in vivo and in vitro
by: Orsolya Palócz, et al.
Published: (2017-06-01)

Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs
by: Léa Darnaud, et al.
Published: (2023-03-01)

Cytochrome P450 genes expression in human prostate cancer
by: Oksana Maksymchuk, et al.
Published: (2024-03-01)

Impact of Pomegranate Juice on the Pharmacokinetics of CYP3A4- and CYP2C9-Mediated Drugs Metabolism: A Preclinical and Clinical Review
by: Kenza Mansoor, et al.
Published: (2023-02-01)

Upregulation of CYP 450s expression of immortalized hepatocyte-like cells derived from mesenchymal stem cells by enzyme inducers
by: Limsrichamrern Somchai, et al.
Published: (2011-09-01)

Evaluation of lentinan effects on cytochrome P450 activity in rats by a cocktail method
by: Yiping Lin, et al.
Published: (2019-03-01)

A Novel System for Evaluating the Inhibition Effect of Drugs on Cytochrome P450 Enzymes in vitro Based on Human-Induced Hepatocytes (hiHeps)
by: Yan Li, et al.
Published: (2021-10-01)

Evidence-based capacity of natural cytochrome enzyme inhibitors to increase the effectivity of antineoplastic drugs
by: Laxmi Manthalkar, et al.
Published: (2022-12-01)

Effects of salidroside on rat CYP enzymes by a cocktail of probe drugs
by: Yan-Li Wei, et al.
Published: (2018-04-01)

Molecular Dynamics Simulations of a Cytochrome P450 from <i>Tepidiphilus thermophilus</i> (P450-TT) Reveal How Its Substrate-Binding Channel Opens
by: Abayomi S. Faponle, et al.
Published: (2021-06-01)

Isolation and characterization of the full-length cDNA encoding a member of a novel cytochrome p450 family (CYP320A1) from the tropical freshwater snail, Biomphalaria glabrata, intermediate host for Schistosoma mansoni
by: Anne E Lockyer, et al.
Published: (2005-05-01)

CYPminer: an automated cytochrome P450 identification, classification, and data analysis tool for genome data sets across kingdoms
by: Ohgew Kweon, et al.
Published: (2020-04-01)

Simultaneous determination of 9 CYP450 enzymes in human liver microsomes using LC-MS/MS
by: SHI Zhongbo, et al.
Published: (2021-02-01)

Association of CYP2C9*2 Allele with Sulphonylurea-Induced Hypoglycaemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population
by: Asif Jan, et al.
Published: (2023-08-01)

CYP1A1 and CYP2E1 polymorphism frequencies in a large Brazilian population
by: Renata dos Santos Coura, et al.
Published: (2007-01-01)

Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility
by: Meng Li, et al.
Published: (2019-08-01)

Coumarin-Based Profluorescent and Fluorescent Substrates for Determining Xenobiotic-Metabolizing Enzyme Activities In Vitro
by: Hannu Raunio, et al.
Published: (2020-07-01)

Discovery of a cytochrome P450 enzyme catalyzing the formation of spirooxindole alkaloid scaffold
by: Tuan-Anh M. Nguyen, et al.
Published: (2023-02-01)

The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
by: Sychev DA, et al.
Published: (2018-05-01)

Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer
by: Ying Luo, et al.
Published: (2020-10-01)

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
by: Christopher Blazy, et al.
Published: (2022-06-01)

Determination of the activity of drug-metabolizing enzymes - the prospects for their use in clinical practice
by: V. V. Smirnov, et al.
Published: (2018-02-01)

Pharmacogenomics in Psychiatry Practice: The Value and the Challenges
by: Aminah Alchakee, et al.
Published: (2022-11-01)

<i>Lysiphyllum strychnifolium</i> (Craib) A. Schmitz Extracts Moderate the Expression of Drug-Metabolizing Enzymes: In Vivo Study to Clinical Propose
by: Natthaporn Kuendee, et al.
Published: (2023-02-01)

Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
by: Sabina Semiz, et al.
Published: (2011-02-01)

Human liver microsomes study on the inhibitory effect of plantainoside D on the activity of cytochrome P450 activity
by: Jin Zhou, et al.
Published: (2022-07-01)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
by: Kata W. Pedersen, et al.
Published: (2021-10-01)

Genetic variations in the drug metabolizing enzyme, CYP2E1, among various ethnic populations of Pakistan
by: Sagheer Ahmed, et al.
Published: (2020-08-01)

VDR, SOD-2, and CYP24A1 Gene Expression in Different Genotypes of BsmI SNP of the Vitamin D Receptor Gene in Individuals with Hypovitaminosis
by: Vanessa Rosa Retamoso, et al.
Published: (2023-08-01)

The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy
by: Danxin Wang, et al.
Published: (2012-10-01)

Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome P450
by: M.P. Marques, et al.
Published: (2002-02-01)

Genome-wide identification of the CYP82 gene family in cucumber and functional characterization of CsCYP82D102 in regulating resistance to powdery mildew
by: Hongyu Wang, et al.
Published: (2024-03-01)

A Computational Inter-Species Study on Safrole Phase I Metabolism-Dependent Bioactivation: A Mechanistic Insight into the Study of Possible Differences among Species
by: Lorenzo Pedroni, et al.
Published: (2023-01-01)

Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450—An evaluation of drug-herb interactions risk
by: Misheck Mudyiwa, et al.
Published: (2023-09-01)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
by: Ron H. N. van Schaik, et al.
Published: (2020-09-01)

Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method
by: Jinhui Wang, et al.
Published: (2021-01-01)

Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies
by: Smarakan Sneha, et al.
Published: (2021-03-01)